K

Kiniksa Pharmaceuticals Ltd
D

KNSA

28.400
USD
0.72
(2.60%)
مفتوح الان
حجم التداول
34,567
الربح لكل سهم
0
العائد الربحي
-
P/E
-118
حجم السوق
2,072,375,463
أصول ذات صلة
A
ASND
-1.440
(-0.84%)
170.590 USD
ICLR
ICLR
1.330
(0.93%)
144.250 USD
M
MCRB
-0.45000
(-4.66%)
9.21000 USD
M
MGNX
-0.07000
(-3.98%)
1.69000 USD
O
OMER
-0.27000
(-3.77%)
6.89000 USD
R
RDFN
-0.34000
(-3.55%)
9.25000 USD
S
SGMO
-0.00670
(-0.92%)
0.72130 USD
TEVA
TEVA
-0.420
(-2.51%)
16.320 USD
VRTX
VRTX
2.85
(0.57%)
503.15 USD
المزيد
الأخبار المقالات

العنوان: Kiniksa Pharmaceuticals International plc

القطاع: Healthcare
الصناعة: Drug Manufacturers - Specialty & Generic
Kiniksa Pharmaceuticals International PLC is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases. The company's clinical-stage product candidates include Rilonacept, abiprubart, and mavrilimumab.